Background: Hemodialysis catheter-related bacteremia (HD CRB) is a major complication of long-term hemodialysis (HD) therapy and bacteremia is secondary only to cardiovascular disease as the leading cause of death in patients receiving renal replacement therapy. A large part may be preventable and surveillance is a critical aspect of infection control and prevention. Aim: To analyze incidence, causative species, and treatment of HD CRB in adult chronic HD patients at Nordsjaellands Hospital (NOH), Denmark. Methods: All episodes of bacteremia in the Department of Cardiology, Nephrology and Endocrinology (KNEA), NOH from 2010 to 2013 were analyzed. Inclusion criteria: Adult chronic HD patients with a tunneled dialysis catheter diagnosed with HD CRB. Causative microorganism and antimicrobial treatment were recorded for each episode. Findings: Ninetynine episodes of HD CRB in 72 patients were found with a mean incidence rate of 0.9/1000 catheter-days. Gram-positive bacteria were isolated in 71% of the episodes, gram-negative bacteria in 25%, both in 3%, and yeast in 1%. The most frequently isolated microorganisms were Staphylococcus aureus (33%), Coagulase-negative staphylococci (29%), enterobacteriaceae (20%) and enterococci (8%). The most commonly used empiric antimicrobials were cefuroxime and vancomycin and the overall efficacy was 77%. Conclusion: The well-functioning infection prevention strategy seems to be successful resulting in a relatively low incidence rate of HD CRB compared with that shown in international studies. The high proportion of gram-negative bacteria raises the question as to whether future antimicrobial guidelines should cover both gram-positive and gram-negative bacteria.
References
[1]
Lewis, S.S. and Sexton, D.J. (2013) Metastatic Complications of Bloodstream Infections in Hemodialysis Patients. Seminars in Dialysis, 26, 47-53. http://dx.doi.org/10.1111/sdi.12031
[2]
Goto, M. and Al-Hasan, M.N. (2013) Overall Burden of Bloodstream Infection and Nosocomial Bloodstream Infection in North America and Europe. Clinical Microbiology and Infection, 19, 501-509. http://dx.doi.org/10.1111/1469-0691.12195
[3]
Sogaard, M., Norgaard, M., Dethlefsen, C. and Schonheyder, H.C. (2011) Temporal Changes in the Incidence and 30-Day Mortality Associated with Bacteremia in Hospitalized Patients from 1992 through 2006: A Population-Based Cohort Study. Clinical Infectious Diseases, 52, 61-69. http://dx.doi.org/10.1093/cid/ciq069
[4]
Mokrzycki, M.H., Zhang, M., Cohen, H., Golestaneh, L., Laut, J.M. and Rosenberg, S.O. (2006) Tunnelled Haemodialysis Catheter Bacteraemia: Risk Factors for Bacteraemia Recurrence, Infectious Complications and Mortality. Nephrology Dialysis Transplantation, 21, 1024-1031. http://dx.doi.org/10.1093/ndt/gfi104
Moore, C.L., Besarab, A., Ajluni, M., et al. (2014) Comparative Effectiveness of Two Catheter Locking Solutions to Reduce Catheter-Related Bloodstream Infection in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology, 9, 1232-1239. http://dx.doi.org/10.2215/CJN.11291113
[7]
Marr, K.A., Sexton, D.J., Conlon, P.J., Corey, G.R., Schwab, S.J. and Kirkland, K.B. (1997) Catheter-Related Bacteremia and Outcome of Attempted Catheter Salvage in Patients Undergoing Hemodialysis. Annals of Internal Medicine, 127, 275-280. http://dx.doi.org/10.7326/0003-4819-127-4-199708150-00003
[8]
Lemaire, X., Morena, M., Leray-Moragues, H., et al. (2009) Analysis of Risk Factors for Catheter-Related Bacteremia in 2000 Permanent Dual Catheters for Hemodialysis. Blood Purification, 28, 21-28. http://dx.doi.org/10.1159/000210034
[9]
Saad, T.F. (1999) Bacteremia Associated with Tunneled, Cuffed Hemodialysis Catheters. American Journal of Kidney Diseases, 34, 1114-1124. http://dx.doi.org/10.1016/S0272-6386(99)70018-1
[10]
Thomson, P.C., Stirling, C.M., Geddes, C.C., Morris, S.T. and Mactier, R.A. (2007) Vascular Access in Haemodialysis Patients: a Modifiable Risk Factor for Bacteraemia and Death. QJM, 100, 415-422. http://dx.doi.org/10.1093/qjmed/hcm040
[11]
Fysaraki, M., Samonis, G., Valachis, A., et al. (2013) Incidence, Clinical, Microbiological Features and Outcome of Bloodstream Infections in Patients Undergoing Hemodialysis. International Journal of Medical Sciences, 10, 1632-1638. http://dx.doi.org/10.7150/ijms.6710
[12]
Karkar, A., Bouhaha, B.M. and Dammang, M.L. (2014) Infection Control in Hemodialysis Units: a Quick Access to Essential Elements. Saudi Journal of Kidney Diseases and Transplantation, 25, 496-519. http://dx.doi.org/10.4103/1319-2442.132150
[13]
Vanholder, R., Canaud, B., Fluck, R., et al. (2010) Diagnosis, Prevention and Treatment of Haemodialysis Catheter-Related Bloodstream Infections (CRBSI): A Position Statement of European Renal Best Practice (ERBP). Clinical Kidney Journal, 3, 234-246. http://dx.doi.org/10.1093/ndtplus/sfq041
[14]
CDC—Centers of Disease Control and Prevention (2016) Core Interventions. http://www.cdc.gov/dialysis/prevention-tools/core-interventions.html
[15]
Ethier, J., Mendelssohn, D.C., Elder, S.J., et al. (2008) Vascular Access Use and Outcomes: an International Perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrology Dialysis Transplantation, 23, 3219-3226. http://dx.doi.org/10.1093/ndt/gfn261
[16]
Pedersen, C.B. (2011) The Danish Civil Registration System. Scandinavian Journal of Public Health, 39, 22-25. http://dx.doi.org/10.1177/1403494810387965
[17]
Friedman, N.D., Kaye, K.S., Stout, J.E., et al. (2002) Health Care–Associated Bloodstream Infections in Adults: a Reason to Change the Accepted Definition of Community-Acquired Infections. Annals of Internal Medicine, 137, 791-797. http://dx.doi.org/10.7326/0003-4819-137-10-200211190-00007
[18]
ECDC—European Centre for Disease Prevention and Control (2008) Annual Epidemiological Report on Communicable Diseases in Europe 2008. http://ecdc.europa.eu/en/publications/Publications/0812_SUR_Annual_Epidemiological_Report_ 2008.pdf
[19]
Rosenblum, A., Wang, W., Ball, L.K., Latham, C., Maddux, F.W. and Lacson Jr., E. (2014) Hemodialysis Catheter Care Strategies: A Cluster-Randomized Quality Improvement Initiative.American Journal of Kidney Diseases, 63, 259-267. http://dx.doi.org/10.1053/j.ajkd.2013.08.019
[20]
Abdul Gafor, A.H., Cheong, P.P., Zainal Abidin, A.F., et al. (2014) Antibiogram for Haemodialysis Catheter-related Bloodstream Infections. International Journal of Nephrology, 2014, 1-6. http://dx.doi.org/10.1155/2014/629459
[21]
Alexandraki, I., Sullivan, R., Zaiden, R., et al. (2008) Blood Culture Isolates in Hemodialysis Vascular Catheter-related Bacteremia.The American Journal of the Medical Sciences, 336, 297-302. http://dx.doi.org/10.1097/MAJ.0b013e3181637432
[22]
Boel, J., Sogaard, M., Andreasen, V., Jarlov, J.O. and Arpi, M. (2015) Evaluating Antibiotic Stewardship Programs in Patients with Bacteremia Using Administrative Data: A Cohort Study. European Journal of Clinical Microbiology & Infectious Diseases, 34, 1475-1484. http://dx.doi.org/10.1007/s10096-015-2378-x
[23]
Mandolfo, S., Acconcia, P., Bucci, R., et al. (2014) Hemodialysis Tunneled Central Venous Catheters: Five-year Outcome Analysis.The Journal of Vascular Access, 15, 461-465. http://dx.doi.org/10.5301/jva.5000236
[24]
ECDC—European Centre for Disease Prevention and Control (2013) Antimicrobial Resistance Surveillance in Europe. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe- 2013.pdf
[25]
Bakke, C.K. (2010) Clinical and Cost Effectiveness of Guidelines to Prevent Intravascular Catheter-related Infections in Patients on Hemodialysis. Nephrology Nursing Journal, 37, 601-615.
[26]
Lindberg, C., Downham, G., Buscell, P., Jones, E., Peterson, P. and Krebs, V. (2013) Embracing Collaboration: a Novel Strategy for Reducing Bloodstream Infections in Outpatient Hemodialysis Centers. American Journal of Infection Control, 41, 513-519. http://dx.doi.org/10.1016/j.ajic.2012.07.015
[27]
Lincoln, M. (2011) Preventing Catheter-associated Bloodstream Infections in HemodialysisCenters: the Facility Perspective. Nephrology Nursing Journal, 38, 411-415.
[28]
Downham, G., Jones, E., Peterson, P. and Yaser Mourad, M. (2012) Reducing Bloodstream Infections in an Outpatient Hemodialysis Center-New Jersey, 2008-2011. MMWR Morbidity and Mortality Weekly Report, 61, 169-173.
[29]
George, A., Tokars, J.I., Clutterbuck, E.J., Bamford, K.B., Pusey, C. and Holmes, A.H. (2006) Reducing Dialysis Associated Bacteraemia, and Recommendations for Surveillance in the United Kingdom: Prospective Study. BMJ, 332, 1435. http://dx.doi.org/10.1136/bmj.332.7555.1435